EGM
MCRB icon

Engineers Gate Manager’s Seres Therapeutics MCRB Stock Holding History

Engineers Gate Manager’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,382
Closed -$33.4K – 2396
2025
Q1 		$33.4K Sell
2,382
-1,867
-44% -$29.2K ﹤0.01% 2065
2024
Q4 		$70.6K Sell
4,249
-950
-18% -$15.4K ﹤0.01% 2040
2024
Q3 		$98.4K Buy
5,199
+701
+16% +$14.2K ﹤0.01% 1921
2024
Q2 		$65.1K Buy
4,498
+3,865
+611% +$64.5K ﹤0.01% 1793
2024
Q1 		$9.79K Buy
+633
New +$13.7K ﹤0.01% 1856
2022
Q2 		– Sell
-2,849
Closed -$406K – 2104
2022
Q1 		$406K Sell
2,849
-3,326
-54% -$512K 0.02% 1187
2021
Q4 		$1.03M Buy
6,175
+5,100
+474% +$810K 0.05% 613
2021
Q3 		$150K Buy
+1,075
New +$210K 0.01% 1485
2021
Q2 		– Sell
-970
Closed -$399K – 1853
2021
Q1 		$399K Buy
+970
New +$447K 0.02% 1138
2020
Q4 		– Sell
-721
Closed -$408K – 1863
2020
Q3 		$408K Buy
+721
New +$240K 0.02% 1094

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Engineers Gate Manager's MCRB Position: Q2 2025 in Review

Engineers Gate Manager sold out of Seres Therapeutics (MCRB) in Q2 2025, closing a stake of 2,382 shares — an estimated $33.4K sold.

Engineers Gate Manager first reported a position in MCRB in Q3 2020 and held it in 10 quarters. The position peaked at $1.03M in Q4 2021. 33 funds tracked by Wall St. Rank hold MCRB as of Q2 2025.

  • Engineers Gate Manager reported no remaining Seres Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 2,382 Seres Therapeutics shares in Q2 2025, an estimated $33.4K.
  • Engineers Gate Manager first reported a position in Seres Therapeutics in Q3 2020 and held it in 10 quarters.
  • Engineers Gate Manager's Seres Therapeutics position peaked at $1.03M in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2025.

Based on Engineers Gate Manager's 13F filing for Q2 2025, filed 14 Aug 2025.